Northwest Biotherapeutics to Present at SMi's 5th Annual Cancer Vaccines Show this Month

LONDON - Sept. 7, 2016 - PRLog -- SMi are thrilled to welcome back Northwest Biotherapeutics to the 5^th Annual Conference on Cancer Vaccines when it returns to Central London in a fortnight's time.

Northwest Biotherapeutics, Inc is a clinical stage a biotechnology company developing DCVax® personalized immune therapies for solid tumour cancers.

CEO, Linda Powers, will be presenting on DCVax® and will be discussing the latest developments and manufacturing of their novel personalised immune therapy.

Other event highlights include a spotlight presentation from Roy Baynes, Senior VP & Head of Global Clinical Development at MSD. Delegates will hear insight into the development of Pembrozlizumab monotherapy across tumour types and receive strategic guidance to address primary resistance and treatment failure.

A full speaker line-up and detailed programme is available online at:

http://www.smi-online.co.uk/pharmaceuticals/uk/cancer-vaccines

Cancer Vaccines
5^th Annual Conference: 21^st & 22^nd September
Interactive Workshops: 20^th September

Holiday Inn Kensington Forum Hotel, London UK
Sponsored by Abzena and Northwest Biotherapeutics

---end---

Contact details:

For media enquires contact Teri Arri on +44 (0)20 7827 6162 or email tarri@smi-online.co.uk

To sponsor the event, contact Alia Malick on +44 (0)20 7827 6168 or email amalick@smi-online.co.uk

To contact the sales team, call Matthew Apps on +44 (0)20 7827 6093 or email mapps@smi-online.co.uk

About SMi:

Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world's most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk